• 1660 Citations
  • 22 Scopus h-Index

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Alvaro Moreno Aspitia is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 14 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • 1660 Citations
  • 22 Scopus h-Index
  • 52 Article
  • 11 Review article
  • 3 Letter
  • 2 Comment/debate

Antitumor Activity and Safety of Trastuzumab Deruxtecan in Patients With HER2-Low-Expressing Advanced Breast Cancer: Results From a Phase Ib Study

Modi, S., Park, H., Murthy, R. K., Iwata, H., Tamura, K., Tsurutani, J., Moreno-Aspitia, A., Doi, T., Sagara, Y., Redfern, C., Krop, I. E., Lee, C., Fujisaki, Y., Sugihara, M., Zhang, L., Shahidi, J. & Takahashi, S., Jun 10 2020, In : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 38, 17, p. 1887-1896 10 p.

Research output: Contribution to journalArticle

Open Access
  • 3 Scopus citations

    A pooled analysis of the cardiac events in the trastuzumab adjuvant trials

    de Azambuja, E., Ponde, N., Procter, M., Rastogi, P., Cecchini, R. S., Lambertini, M., Ballman, K., Aspitia, A. M., Zardavas, D., Roca, L., Gelber, R. D., Piccart-Gebhart, M. & Suter, T., Jan 1 2020, In : Breast Cancer Research and Treatment. 179, 1, p. 161-171 11 p.

    Research output: Contribution to journalArticle

  • 6 Scopus citations

    Long-term cardiac outcomes of patients with HER2-positive breast cancer treated in the adjuvant lapatinib and/or trastuzumab Treatment Optimization Trial

    Eiger, D., Pondé, N. F., Agbor-Tarh, D., Moreno-Aspitia, A., Piccart, M., Hilbers, F. S., Werner, O., Chumsri, S., Dueck, A., Kroep, J. R., Gomez, H., Láng, I., Rodeheffer, R. J., Ewer, M. S., Suter, T. & de Azambuja, E., May 12 2020, In : British journal of cancer. 122, 10, p. 1453-1460 8 p.

    Research output: Contribution to journalArticle

  • N083E (Alliance): long-term outcomes of patients treated in a pilot phase II study of docetaxel, carboplatin, trastuzumab, and lapatinib as adjuvant therapy for early-stage HER2-positive breast cancer

    Leon-Ferre, R. A., Perez, E. A., Hillman, D. W., Bueno, C., Perez, A. T., Chen, B., Jenkins, R. B., Northfelt, D. W., Johnson, D. B., Carolla, R. L., Zon, R. T. & Moreno-Aspitia, A., Aug 1 2020, In : Breast Cancer Research and Treatment. 182, 3, p. 613-622 10 p.

    Research output: Contribution to journalArticle

  • Personalized Management of Chemotherapy-Induced Peripheral Neuropathy Based on a Patient Reported Outcome: CALGB 40502 (Alliance)

    Sharma, M. R., Mehrotra, S., Gray, E., Wu, K., Barry, W. T., Hudis, C., Winer, E. P., Lyss, A. P., Toppmeyer, D. L., Moreno-Aspitia, A., Lad, T. E., Velasco, M., Overmoyer, B., Rugo, H. S., Ratain, M. J. & Gobburu, J. V., Apr 1 2020, In : Journal of Clinical Pharmacology. 60, 4, p. 444-452 9 p.

    Research output: Contribution to journalArticle